Griffiths Richard Ian's Form 4 filing
Silence Therapeutics plc (SLN) · filed Mar 6, 2025
- Accession no.
- 0001104659-25-021245
- Filed
- Mar 6, 2025
- Trade date
- Mar 5, 2025
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not checked
This filing lists 1 derivative transaction. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Griffiths Richard IanCIK 0001846370 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
This filing has no transactions of this kind.
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 5, 2025 | Ordinary Shares | PPurchaseAcquired | +67,896 | –F1 | – | 9,561,299 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
Each American Depositary Share ("ADS") is immediately convertible into three ordinary shares for no consideration and has no expiration date.
Referenced by the price of 1 transaction in Table II.